(Q42651351)

English

Assessment of the effects of renal impairment on the pharmacokinetic profile of laninamivir, a novel neuraminidase inhibitor, after a single inhaled dose of its Prodrug, CS-8958.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Assessment of the effects of renal impairment on the pharmacokinetic profile of laninamivir, a novel neuraminidase inhibitor, after a single inhaled dose of its Prodrug, CS-8958. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Hitoshi Ishizuka

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Satoshi Yoshiba

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Kazutaka Yoshihara

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Hiromi Okabe

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

2 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

243-251

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Developing new antiviral agents for influenza treatment: what does the future hold?

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361914

21 January 2018

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361914

21 January 2018

Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361914

21 January 2018

CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361914

21 January 2018

Synthesis and in vivo influenza virus-inhibitory effect of ester prodrug of 4-guanidino-7-O-methyl-Neu5Ac2en

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361914

21 January 2018

Emergence and pandemic potential of swine-origin H1N1 influenza virus

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361914

21 January 2018

CS-8958, a prodrug of the novel neuraminidase inhibitor R-125489, demonstrates a favorable long-retention profile in the mouse respiratory tract

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361914

21 January 2018

Pharmacokinetics and disposition of CS-8958, a long-acting prodrug of the novel neuraminidase inhibitor laninamivir in rats

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361914

21 January 2018

Drug dosing in patients with impaired renal function

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361914

21 January 2018

Emerging evidence of the impact of kidney disease on drug metabolism and transport

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361914

21 January 2018

Identifiers

10.1177/0091270010361914

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42651351&oldid=2143669229"